MICROSCOPIC POLYANGIITIS (MPA)

Clinical trials for MICROSCOPIC POLYANGIITIS (MPA) explained in plain language.

Never miss a new study

Get alerted when new MICROSCOPIC POLYANGIITIS (MPA) trials appear

Sign up with your email to follow new studies for MICROSCOPIC POLYANGIITIS (MPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

Blood test triggers treatment to stop autoimmune Flare-Ups

Disease control Not yet recruiting

This study aims to find a better way to prevent disease flare-ups in people with two rare autoimmune conditions (GPA and MPA). It will compare two approaches: giving a treatment called rituximab as soon as a specific blood marker rises, versus the current standard of just monitor…

Matched conditions: MICROSCOPIC POLYANGIITIS (MPA)

Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

MICROSCOPIC POLYANGIITIS (MPA)

Get alerted when new MICROSCOPIC POLYANGIITIS (MPA) trials appear

Blood test triggers treatment to stop autoimmune Flare-Ups